Skip to main content
Livermore
Livermore
ZHEN

Ultragenyx Pharmaceutical Inc.

RARE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001515673

In the last 90 days, Ultragenyx Pharmaceutical Inc. insiders filed 0 open-market purchases and 4 sales; 311 institutions reported holding it in 13F filings for Q2 2026, worth $3.55B in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding Ultragenyx Pharmaceutical Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of RARE: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders230243+13
Shares68.7M69.5M+800.6K (+1.2%)
Value$2.76B$3.21B+$450.4M (+16.3%)

New holders (41)

Institutions that held Ultragenyx Pharmaceutical Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to RARE in Q2 2023
InstitutionSharesValue% of portfolio
Sands Capital Management, LLC2,673,638$123.3M0.38%
Driehaus Capital Management LLC329,668$15.2M0.19%
Woodline Partners LP236,564$10.9M0.13%
Ikarian Capital, LLC121,658$5.61M1.98%
CHI Advisors LLC85,000$3.92M1.19%
Natixis64,700$2.98M0.03%
PDT Partners, LLC33,229$1.53M0.21%
Harbor Capital Advisors, Inc.25,972$1.20M0.24%
Captrust Financial Advisors24,840$1.15M0.00%
Boothbay Fund Management, LLC24,794$1.14M0.04%
Renaissance Technologies LLC19,600$904.0K0.00%
Duality Advisers, LP14,323$660.7K0.08%
Seven Eight Capital, LP13,804$636.8K0.11%
DnB Asset Management AS11,826$545.5K0.00%
Squarepoint Ops LLC11,558$533.2K0.00%
Raymond James Financial Services Advisors, Inc.9,705$447.7K0.00%
Gilder Gagnon Howe & Co LLC9,648$445.1K0.01%
Allianz Asset Management GmbH8,500$392.1K0.00%
HighVista Strategies LLC7,326$337.9K0.15%
Corton Capital Inc.6,062$279.6K0.13%
PEAK6 Investments LLC5,999$276.7K0.02%
Vident Investment Advisory, LLC5,893$271.8K0.01%
Bridgefront Capital, LLC5,702$263.0K0.14%
Stifel Financial Corp5,497$253.6K0.00%
Fox Run Management, L.L.C.4,887$225.4K0.06%
Prelude Capital Management, LLC4,788$220.9K0.02%
Maryland State Retirement & Pension System4,688$216.3K0.00%
M&T Bank Corp4,474$206.0K0.00%
Aigen Investment Management, LP4,420$203.9K0.03%
Column Capital Advisors, LLC1,704$78.6K0.01%
Van Eck Associates Corp1,149$53.0K0.00%
Umb Bank N A434$20.0K0.00%
Huntington National Bank364$16.8K0.00%
St Germain D J Co Inc300$13.8K0.00%
Walleye Trading LLC300$13.8K0.00%
Caldwell Sutter Capital, Inc.123$5.67K0.00%
Loomis Sayles & Co L P85$4.00K0.00%
Proequities, Inc.13$5990.00%
Versant Capital Management, Inc12$5540.00%
Crewe Advisors LLC3$1390.00%
Comerica Bank2,555$160.00%

Sold out (28)

Institutions that held Ultragenyx Pharmaceutical Inc. at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of RARE in Q2 2023
InstitutionShares, Q1 2023Value, Q1 2023
Nomura Holdings Inc329,170$13.2M
ExodusPoint Capital Management, LP70,864$2.84M
Congress Wealth Management LLC70,438$2.82M
Tekla Capital Management LLC67,065$2.69M
Alps Advisors Inc46,259$1.85M
Bank of Nova Scotia38,200$1.53M
AQR Capital Management LLC35,911$1.41M
Vontobel Holding Ltd.28,424$1.14M
Gsa Capital Partners LLP27,326$1.10M
Schonfeld Strategic Advisors LLC19,474$780.9K
Caption Management, LLC18,024$722.8K
Bayesian Capital Management, LP16,263$652.1K
Capital Fund Management S.A.14,398$577.4K
Echo Street Capital Management LLC9,183$368.2K
Group One Trading, L.P.8,648$346.8K
Winton Group Ltd8,518$341.6K
Nebula Research & Development LLC8,050$322.8K
Edgestream Partners, L.P.6,666$267.3K
Rockefeller Capital Management L.P.6,247$249.0K
Systematic Financial Management LP2,668$107.0K
Values First Advisors, Inc.1,489$59.7K
Harbor Investment Advisory, LLC659$26.4K
Baillie Gifford & Co115$4.61K
International Assets Investment Management, LLC47$1.89K
Machina Capital S.A.S.22$882
Ellevest, Inc.11$441
Northwestern Mutual Wealth Management Co5$201
Advisory Services Network, LLC1$40